New data from Janssen presented at the Annual European Congress of...
The Janssen Pharmaceutical Companies of Johnson & Johnson presented this week results of two analyses from a Phase 2 study of Stelara ustekinumab in systemic lupus erythematosus SLE. The...
View ArticleTreating Crohn's with adalimumab may boost remission rates study says
Patients who were treated with adalimumab within two years of Crohn's disease diagnosis had a better chance of achieving remi More
View ArticleGranulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha...
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA Pipeline Review H1 2019SummaryAccording to the recently published report 'Granulocyte Macrophage Colony...
View ArticleJanssen Reports TopLine Phase 3 Results for TREMFYAÂ guselkumab in Adults...
Data are part of the DISCOVER 1 and 2 programme the first Phase 3 studies to evaluate a selective IL23 p19 inhibitor in the treatment of psoriatic arthritis The Janssen Pharmaceutical Companies of...
View ArticleMorphoSys's Licensee Janssen Announces Topline Phase 3 Results for Guselkumab...
DGAPNews MorphoSys AG Key words Study14.06.2019 1358 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany June 14 2019MorphoSys's Licensee Janssen Announces...
View ArticleReistone Announces First Patient Dosed in Two Phase II Global Studies of...
SHANGHAI June 14 2019 PRNewswire Reistone Biopharma Company Limited Reistone announced today dosing of the first patient in their Phase II global clinical trials RSJ10101 and RSJ10201 of SHR0302 in...
View ArticleReistone Starts Global Trial of ChinaDiscovered JAK1 Inhibitor for IBD
Reistone a oneyearold ShanghaiBeijingBoston biopharma has dosed the first patient in global Phase II trial of its JAK1 inhibitor in patients with Ulcerative Colitis and Crohn's disease. The JAK1...
View ArticleAbbVie BI settle IP litigation surrounding BI's Cyltezo a Humira biosimilar
AbbVie and Boehringer Ingelheim GmbH resolved all ongoing intellectual property litigation regarding BI's Cyltezo adalimumabadbm a biosimilar to AbbVie's Humira adalimumab. Cyltezo was FDA approved in...
View ArticleCombination Diet Improves CD in Children
MedPage Today Exclusion Crohn's Disease diet plus partial enteral nutrition produces sustained remissions is welltolerated
View ArticleResearch highlights possible targets to help tackle Crohn's disease
University of Plymouth There is no precise cure for digestive condition Crohn's disease and causes are believed to vary. But one indicator of the condition an abnormal reaction of the immune system to...
View ArticlePossible targets to help tackle Crohn's disease
There is no precise cure for digestive condition Crohn's disease and causes are believed to vary. But one indicator of the condition an abnormal reaction of the immune system to certain bacteria in the...
View ArticleResearch highlights potential targets to help fight Crohn's disease
Affecting around 115000 people in the UK alone Crohn's disease is a lifelong condition which sees parts of the digestive system become inflamed.
View ArticleCara Care Raises $7M Series A Led by Johnson & Johnson Innovation JJDC Inc....
Company will use funds to scale its Cara Care digital therapeutic for lifeinterrupting digestive diseases Digital health company HiDoc Technologies GmbH dba Cara Care today announced that it has raised...
View ArticleGali Health Makes Intelligent Personal Health Assistant Available to More...
Patient advocates endorsement and over $2 million in seed capital bring the Gali mobile application to more people living with inflammatory bowel diseasesGali Health a health technology company working...
View ArticleBiologics in IBD More Thoughtful Use Could Improve Outcomes
The marketplace introduction of infliximab for the treatment of IBD did not reduce hospitalization or surgery rates in a large population of patients with Crohn disease and ulcerative colitis. Medscape...
View ArticlePlantbased diet leads to Crohn's Disease remission according to case study
Physicians Committee for Responsible Medicine Eating a plantbased diet may be an effective treatment for Crohn's disease according to a case study published in the journal Nutrients.
View ArticleResearch Roundup What Causes Crohns Disease
Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones.
View ArticlePlantbased diet may be effective treatment for Crohn's disease
Eating a plantbased diet may be an effective treatment for Crohn's disease according to a case study published in the journal Nutrients.
View ArticleCure Crohn's Disease With This Diet
A recent case report published in the journal Nutrients demonstrates that eating a plantbased diet may be an effective treatment to help induce remission in Crohn's disease.
View Article